Valle Palomo Ruiz
Valle Palomo Ruiz
IMDEA Nanociencia
Подтвержден адрес электронной почты в домене
Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo
JA Morales-Garcia, R Luna-Medina, S Alonso-Gil, M Sanz-SanCristobal, ...
ACS chemical neuroscience 3 (11), 963-971, 2012
Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice
AV Franklin, MK King, V Palomo, A Martinez, LL McMahon, RS Jope
Biological psychiatry 75 (3), 198-206, 2014
Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities
V Palomo, I Soteras, DI Perez, C Pérez, C Gil, NE Campillo, A Martinez
Journal of medicinal chemistry, 2011
Photoligation of an amphiphilic polymer with mixed coordination provides compact and reactive quantum dots
W Wang, A Kapur, X Ji, M Safi, G Palui, V Palomo, PE Dawson, ...
Journal of the American Chemical Society 137 (16), 5438-5451, 2015
5-Imino-1, 2, 4-Thiadiazoles: First Small Molecules As Substrate Competitive Inhibitors of Glycogen Synthase Kinase 3
V Palomo, DI Perez, C Pérez, JA Morales, I Soteras, S Alonso-Gil, ...
Journal of Medicinal Chemistry, 2012
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds
DI Perez, V Palomo, C P rez, C Gil, PD Dans, FJ Luque, S Conde, ...
Journal of medicinal chemistry, 2011
Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3
E Beurel, O Kaidanovich-Beilin, WI Yeh, L Song, V Palomo, SM Michalek, ...
The Journal of Immunology 190 (10), 5000-5011, 2013
PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury
I Paterniti, E Mazzon, C Gil, D Impellizzeri, V Palomo, M Redondo, ...
PloS one 6 (1), e15937, 2011
Delivery and tracking of quantum dot peptide bioconjugates in an intact developing avian brain
R Agarwal, MS Domowicz, NB Schwartz, J Henry, I Medintz, JB Delehanty, ...
ACS chemical neuroscience 6 (3), 494-504, 2015
Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.
JA Morales-Garcia, C Susin, S Alonso-Gil, DI Perez, V Palomo, C Pérez, ...
ACS Chemical Neuroscience, 2013
Purple-, blue-, and green-emitting multishell alloyed quantum dots: synthesis, characterization, and application for ratiometric extracellular pH sensing
K Susumu, LD Field, E Oh, M Hunt, JB Delehanty, V Palomo, PE Dawson, ...
Chemistry of Materials 29 (17), 7330-7344, 2017
UV and sunlight driven photoligation of quantum dots: understanding the photochemical transformation of the ligands
F Aldeek, D Hawkins, V Palomo, M Safi, G Palui, PE Dawson, I Alabugin, ...
Journal of the American Chemical Society 137 (7), 2704-2714, 2015
Dual inhibitor of PDE7 and GSK-3–VP1. 15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice
TV Lipina, V Palomo, C Gil, A Martinez, JC Roder
Neuropharmacology 64, 205-214, 2013
T cells control the generation of nanomolar-affinity anti-glycan antibodies
Z Polonskaya, S Deng, A Sarkar, L Kain, M Comellas-Aragones, ...
The Journal of clinical investigation 127 (4), 1491-1504, 2017
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival
EM Medina-Rodríguez, FJ Arenzana, J Pastor, M Redondo, V Palomo, ...
Cellular and molecular life sciences 70 (18), 3449-3462, 2013
Subtly modulating glycogen synthase kinase 3 β: allosteric inhibitor development and their potential for the treatment of chronic diseases
V Palomo, DI Perez, C Roca, C Anderson, N Rodríguez-Muela, C Perez, ...
Journal of medicinal chemistry 60 (12), 4983-5001, 2017
Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015)
V Palomo, A Martinez
Expert opinion on therapeutic patents 27 (6), 657-666, 2017
The Potential Role of Glycogen Synthase Kinase 3 Inhibitors as Amyotrophic Lateral Sclerosis Pharmacological Therapy
V Palomo, D I Perez, C Gil, A Martinez
Current medicinal chemistry 18 (20), 3028-3034, 2011
5-Imino-1, 2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: Determination of blood–brain barrier …
DI Pérez, M Pistolozzi, V Palomo, M Redondo, C Fortugno, C Gil, G Felix, ...
European Journal of Pharmaceutical Sciences, 2012
Promoting in vivo remyelination with small molecules: A neuroreparative pharmacological treatment for Multiple Sclerosis
EM Medina-Rodríguez, A Bribián, A Boyd, V Palomo, J Pastor, A Lagares, ...
Scientific reports 7 (1), 1-14, 2017
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20